{
    "hands_on_practices": [
        {
            "introduction": "Our journey into modeling oral drug administration begins with the most fundamental task: deriving the mathematical equation that describes drug concentration over time. Starting from basic mass-balance principles, this practice guides you through the process of setting up and solving the differential equations for a one-compartment model with first-order absorption. Mastering this derivation  provides the foundational tool, the Bateman function, upon which all further analysis is built.",
            "id": "3915182",
            "problem": "Consider a one-compartment oral dosing model with first-order absorption and first-order elimination. A single oral dose $D$ is administered at time $t=0$ with systemic bioavailability $F$. Let $A_{g}(t)$ denote the amount of drug in the gastrointestinal tract and $A_{c}(t)$ the amount of drug in the central compartment. The initial conditions are $A_g(0)=D$ and $A_c(0)=0$. The absorption from the gastrointestinal tract to the central compartment is first-order with absorption rate constant $k_{a}$, and elimination from the central compartment is first-order with elimination rate constant $k_{e}$. The central compartment has volume of distribution $V$. \n\nStarting from mass-balance statements and the governing ordinary differential equations (ODEs) implied by these assumptions, derive the expression for the concentration-time profile $C(t)$ in the central compartment following the single oral dose (this expression is widely known as the Bateman function). Then, using $F=0.9$, $D=100$ mg, $V=30$ L, $k_{a}=1.2$ $\\text{h}^{-1}$, $k_{e}=0.2$ $\\text{h}^{-1}$, and evaluating at $t=1$ $\\text{h}$, compute $C(1)$. Round your numerical result to four significant figures and express the concentration in milligrams per liter (mg/L). The final answer must be a single real number.",
            "solution": "First, we establish the mass-balance equations for the amount of drug in the gastrointestinal (GI) tract, $A_{g}(t)$, and in the central compartment, $A_{c}(t)$.\n\nThe rate of change of the amount of drug in the GI tract is governed by first-order absorption:\n$$ \\frac{dA_{g}}{dt} = -k_{a} A_{g}(t) $$\nThe initial amount of drug in the GI tract at $t=0$ is the full dose $D$:\n$$ A_{g}(0) = D $$\nThe solution to this first-order ordinary differential equation (ODE) is:\n$$ A_{g}(t) = D \\exp(-k_{a} t) $$\n\nThe rate of change of the amount of drug in the central compartment depends on the rate of absorption from the GI tract (scaled by bioavailability $F$) and the rate of elimination from the central compartment:\n$$ \\frac{dA_{c}}{dt} = F \\cdot k_{a} A_{g}(t) - k_{e} A_{c}(t) $$\nThe initial condition is that there is no drug in the central compartment at $t=0$:\n$$ A_{c}(0) = 0 $$\nSubstitute the expression for $A_{g}(t)$ into the equation for $A_{c}(t)$:\n$$ \\frac{dA_{c}}{dt} = F k_{a} D \\exp(-k_{a} t) - k_{e} A_{c}(t) $$\nThis is a first-order linear non-homogeneous ODE, which can be rearranged into the standard form:\n$$ \\frac{dA_{c}}{dt} + k_{e} A_{c}(t) = F k_{a} D \\exp(-k_{a} t) $$\nWe solve this ODE using an integrating factor, $I(t)$, defined as $I(t) = \\exp(\\int k_e dt) = \\exp(k_e t)$. Multiplying the ODE by $I(t)$:\n$$ \\exp(k_e t) \\frac{dA_{c}}{dt} + k_{e} \\exp(k_e t) A_{c}(t) = F k_{a} D \\exp(-k_a t) \\exp(k_e t) $$\nThe left side is the derivative of the product $A_{c}(t) \\exp(k_e t)$:\n$$ \\frac{d}{dt} \\left( A_{c}(t) \\exp(k_e t) \\right) = F k_{a} D \\exp((k_e - k_a)t) $$\nIntegrating both sides with respect to $t$, assuming $k_a \\neq k_e$ as given by the problem parameters:\n$$ A_{c}(t) \\exp(k_e t) = \\int F k_{a} D \\exp((k_e - k_a)t) dt = F k_{a} D \\frac{\\exp((k_e - k_a)t)}{k_e - k_a} + C_{int} $$\nwhere $C_{int}$ is the constant of integration. To solve for $A_c(t)$, we divide by $\\exp(k_e t)$:\n$$ A_{c}(t) = \\frac{F k_{a} D}{k_e - k_a} \\exp(-k_a t) + C_{int} \\exp(-k_e t) $$\nWe use the initial condition $A_{c}(0)=0$ to find $C_{int}$:\n$$ 0 = \\frac{F k_{a} D}{k_e - k_a} \\exp(0) + C_{int} \\exp(0) \\implies C_{int} = -\\frac{F k_{a} D}{k_e - k_a} $$\nSubstituting $C_{int}$ back into the expression for $A_{c}(t)$:\n$$ A_{c}(t) = \\frac{F k_{a} D}{k_e - k_a} \\exp(-k_a t) - \\frac{F k_{a} D}{k_e - k_a} \\exp(-k_e t) $$\n$$ A_{c}(t) = \\frac{F k_{a} D}{k_e - k_a} (\\exp(-k_a t) - \\exp(-k_e t)) $$\nBy convention, the denominator is often written as $k_a - k_e$:\n$$ A_{c}(t) = \\frac{F k_{a} D}{k_a - k_e} (\\exp(-k_e t) - \\exp(-k_a t)) $$\nThe concentration in the central compartment, $C(t)$, is the amount of drug $A_{c}(t)$ divided by the volume of distribution $V$:\n$$ C(t) = \\frac{A_{c}(t)}{V} = \\frac{F k_{a} D}{V(k_a - k_e)} (\\exp(-k_e t) - \\exp(-k_a t)) $$\nThis is the Bateman function for oral drug administration.\n\nNow, we compute the concentration at $t=1$ h using the given numerical values:\n$F = 0.9$\n$D = 100$ mg\n$V = 30$ L\n$k_a = 1.2$ h$^{-1}$\n$k_e = 0.2$ h$^{-1}$\n$t = 1$ h\n\nSubstitute these values into the expression for $C(t)$:\n$$ C(1) = \\frac{(0.9)(1.2 \\, \\text{h}^{-1})(100 \\, \\text{mg})}{(30 \\, \\text{L})(1.2 \\, \\text{h}^{-1} - 0.2 \\, \\text{h}^{-1})} (\\exp(-(0.2 \\, \\text{h}^{-1})(1 \\, \\text{h})) - \\exp(-(1.2 \\, \\text{h}^{-1})(1 \\, \\text{h}))) $$\nFirst, calculate the pre-factor:\n$$ \\text{Pre-factor} = \\frac{0.9 \\times 1.2 \\times 100}{30 \\times (1.0)} \\, \\frac{\\text{mg}}{\\text{L}} = \\frac{108}{30} \\, \\frac{\\text{mg}}{\\text{L}} = 3.6 \\, \\frac{\\text{mg}}{\\text{L}} $$\nNext, calculate the exponential term:\n$$ \\text{Exponential term} = \\exp(-0.2) - \\exp(-1.2) $$\n$$ \\exp(-0.2) \\approx 0.81873075... $$\n$$ \\exp(-1.2) \\approx 0.30119421... $$\n$$ \\text{Exponential term} \\approx 0.81873075 - 0.30119421 = 0.51753654... $$\nFinally, multiply the pre-factor by the exponential term:\n$$ C(1) = 3.6 \\times 0.51753654... \\approx 1.86313154... \\, \\frac{\\text{mg}}{\\text{L}} $$\nRounding the result to four significant figures as requested:\n$$ C(1) \\approx 1.863 \\, \\frac{\\text{mg}}{\\text{L}} $$",
            "answer": "$$\n\\boxed{1.863}\n$$"
        },
        {
            "introduction": "With the concentration-time profile established, we can now extract clinically meaningful parameters that define a drug's peak effect. This exercise  focuses on finding the time to maximum concentration ($t_{\\max}$) and the value of that peak concentration ($C_{\\max}$). By applying calculus to the Bateman function, you will develop the skills to predict key metrics used in determining appropriate dosing regimens and ensuring patient safety.",
            "id": "3915204",
            "problem": "A single oral dose is administered to a patient whose systemic disposition is well-described by a one-compartment model with first-order absorption and first-order elimination. Let $A_{g}(t)$ denote the amount of drug in the gastrointestinal tract, and let $A_{c}(t)$ denote the amount of drug in the central (plasma) compartment. Assume an immediate placement of the oral dose in the gastrointestinal tract at $t=0$, so that $A_{g}(0)=D$ and $A_{c}(0)=0$. The bioavailability fraction is $F$, the first-order absorption rate constant is $k_{a}$, the first-order elimination rate constant is $k_{e}$, and the volume of distribution is $V$. Drug is absorbed from the gastrointestinal tract into the central compartment and eliminated from the central compartment. Using conservation of mass and the definitions given, derive the plasma concentration $C(t)$, then determine the time of maximum concentration $t_{\\max}$ and the maximum concentration $C_{\\max}$.\n\nUsing the parameter values $k_{a}=0.8\\,\\mathrm{h}^{-1}$, $k_{e}=0.2\\,\\mathrm{h}^{-1}$, $F=0.7$, $D=80\\,\\mathrm{mg}$, and $V=25\\,\\mathrm{L}$, compute numerical values for $t_{\\max}$ and $C_{\\max}$. Round your answers to four significant figures. Report $t_{\\max}$ in hours ($\\mathrm{h}$) and $C_{\\max}$ in milligrams per liter ($\\mathrm{mg}/\\mathrm{L}$).",
            "solution": "The model is based on the principles of mass conservation. The rate of change of the amount of drug in the gastrointestinal tract, $A_{g}(t)$, is described by a first-order decay process representing absorption:\n$$ \\frac{dA_{g}}{dt} = -k_{a} A_{g}(t) $$\nWith the initial condition $A_{g}(0) = D$, this differential equation has the solution:\n$$ A_{g}(t) = D \\exp(-k_{a} t) $$\nThe rate of change of the amount of drug in the central compartment, $A_{c}(t)$, is determined by the rate of drug absorption from the GI tract and the rate of drug elimination from the central compartment. The rate of absorption is proportional to the amount of drug in the GI tract, $k_{a} A_{g}(t)$, and scaled by the bioavailability fraction $F$. The rate of elimination is a first-order process, proportional to the amount of drug in the central compartment, $k_{e} A_{c}(t)$.\nThe resulting differential equation for $A_{c}(t)$ is:\n$$ \\frac{dA_{c}}{dt} = F k_{a} A_{g}(t) - k_{e} A_{c}(t) $$\nSubstituting the expression for $A_{g}(t)$, we obtain a first-order linear non-homogeneous ordinary differential equation:\n$$ \\frac{dA_{c}}{dt} + k_{e} A_{c}(t) = F k_{a} D \\exp(-k_{a} t) $$\nThis equation can be solved using an integrating factor, $I(t) = \\exp(\\int k_{e} dt) = \\exp(k_{e} t)$. Multiplying the equation by $I(t)$ yields:\n$$ \\exp(k_{e} t) \\frac{dA_{c}}{dt} + k_{e} \\exp(k_{e} t) A_{c}(t) = F k_{a} D \\exp(-k_{a} t) \\exp(k_{e} t) $$\nThe left side is the derivative of a product:\n$$ \\frac{d}{dt} \\left( A_{c}(t) \\exp(k_{e} t) \\right) = F k_{a} D \\exp((k_{e} - k_{a}) t) $$\nIntegrating both sides with respect to $t$, assuming $k_{a} \\neq k_{e}$:\n$$ A_{c}(t) \\exp(k_{e} t) = \\int F k_{a} D \\exp((k_{e} - k_{a}) t) dt = \\frac{F k_{a} D}{k_{e} - k_{a}} \\exp((k_{e} - k_{a}) t) + \\text{C} $$\nwhere $\\text{C}$ is the constant of integration. Solving for $A_{c}(t)$:\n$$ A_{c}(t) = \\frac{F k_{a} D}{k_{e} - k_{a}} \\exp(-k_{a} t) + \\text{C} \\exp(-k_{e} t) $$\nUsing the initial condition $A_{c}(0) = 0$:\n$$ 0 = \\frac{F k_{a} D}{k_{e} - k_{a}} \\exp(0) + \\text{C} \\exp(0) \\implies \\text{C} = -\\frac{F k_{a} D}{k_{e} - k_a} $$\nSubstituting the constant back into the solution for $A_{c}(t)$:\n$$ A_{c}(t) = \\frac{F k_{a} D}{k_{e} - k_{a}} (\\exp(-k_{a} t) - \\exp(-k_{e} t)) $$\nThe plasma concentration $C(t)$ is $A_{c}(t)/V$. To present the equation in its conventional form where the denominator is positive (since for oral absorption, typically $k_a > k_e$), we multiply the numerator and denominator by $-1$:\n$$ C(t) = \\frac{F k_{a} D}{V(k_a - k_e)} (\\exp(-k_e t) - \\exp(-k_a t)) $$\nTo find the time of maximum concentration, $t_{\\max}$, we find the time at which the first derivative of $C(t)$ with respect to $t$ is zero:\n$$ \\frac{dC}{dt} = \\frac{F k_{a} D}{V(k_a - k_e)} \\frac{d}{dt}(\\exp(-k_e t) - \\exp(-k_a t)) $$\n$$ \\frac{dC}{dt} = \\frac{F k_{a} D}{V(k_a - k_e)} (-k_e \\exp(-k_e t) + k_a \\exp(-k_a t)) $$\nSetting $\\frac{dC}{dt} = 0$ at $t = t_{\\max}$:\n$$ -k_e \\exp(-k_e t_{\\max}) + k_a \\exp(-k_a t_{\\max}) = 0 $$\n$$ k_a \\exp(-k_a t_{\\max}) = k_e \\exp(-k_e t_{\\max}) $$\n$$ \\frac{k_a}{k_e} = \\frac{\\exp(-k_e t_{\\max})}{\\exp(-k_a t_{\\max})} = \\exp((k_a - k_e) t_{\\max}) $$\nTaking the natural logarithm of both sides and solving for $t_{\\max}$:\n$$ \\ln\\left(\\frac{k_a}{k_e}\\right) = (k_a - k_e) t_{\\max} $$\n$$ t_{\\max} = \\frac{\\ln(k_a/k_e)}{k_a - k_e} = \\frac{\\ln(k_a) - \\ln(k_e)}{k_a - k_e} $$\nThe maximum concentration, $C_{\\max}$, is found by substituting $t=t_{\\max}$ into the expression for $C(t)$.\n$$ C_{\\max} = C(t_{\\max}) = \\frac{F k_{a} D}{V(k_a - k_e)} (\\exp(-k_e t_{\\max}) - \\exp(-k_a t_{\\max})) $$\nThis expression can be simplified. From the condition at $t_{\\max}$, we have $\\exp(-k_a t_{\\max}) = \\frac{k_e}{k_a} \\exp(-k_e t_{\\max})$. Substituting this into the equation for $C_{\\max}$:\n$$ C_{\\max} = \\frac{F k_{a} D}{V(k_a - k_e)} \\left(\\exp(-k_e t_{\\max}) - \\frac{k_e}{k_a} \\exp(-k_e t_{\\max})\\right) $$\n$$ C_{\\max} = \\frac{F k_{a} D}{V(k_a - k_e)} \\exp(-k_e t_{\\max}) \\left(1 - \\frac{k_e}{k_a}\\right) $$\n$$ C_{\\max} = \\frac{F k_{a} D}{V(k_a - k_e)} \\exp(-k_e t_{\\max}) \\left(\\frac{k_a - k_e}{k_a}\\right) $$\n$$ C_{\\max} = \\frac{F D}{V} \\exp(-k_e t_{\\max}) $$\n\nNow we compute the numerical values using the given parameters: $k_{a}=0.8\\,\\mathrm{h}^{-1}$, $k_{e}=0.2\\,\\mathrm{h}^{-1}$, $F=0.7$, $D=80\\,\\mathrm{mg}$, and $V=25\\,\\mathrm{L}$.\n\nFirst, we compute $t_{\\max}$:\n$$ t_{\\max} = \\frac{\\ln(0.8 / 0.2)}{0.8 - 0.2} = \\frac{\\ln(4)}{0.6} \\approx \\frac{1.386294}{0.6} \\approx 2.31049\\,\\mathrm{h} $$\nRounding to four significant figures, $t_{\\max} = 2.310\\,\\mathrm{h}$.\n\nNext, we compute $C_{\\max}$ using the simplified expression:\n$$ C_{\\max} = \\frac{F D}{V} \\exp(-k_e t_{\\max}) $$\nUsing the unrounded value for $t_{\\max}$:\n$$ C_{\\max} = \\frac{0.7 \\times 80}{25} \\exp\\left(-0.2 \\times \\frac{\\ln(4)}{0.6}\\right) = 2.24 \\exp\\left(-\\frac{1}{3}\\ln(4)\\right) $$\n$$ C_{\\max} = 2.24 \\exp(\\ln(4^{-1/3})) = 2.24 \\times 4^{-1/3} = \\frac{2.24}{\\sqrt[3]{4}} $$\n$$ C_{\\max} \\approx \\frac{2.24}{1.587401} \\approx 1.41111\\,\\mathrm{mg}/\\mathrm{L} $$\nRounding to four significant figures, $C_{\\max} = 1.411\\,\\mathrm{mg}/\\mathrm{L}$.",
            "answer": "$$\\boxed{\\begin{pmatrix} 2.310  1.411 \\end{pmatrix}}$$"
        },
        {
            "introduction": "The shape of the concentration curve at late time points holds the key to understanding which physiological process governs the drug's eventual removal from the body. This advanced practice  delves into analyzing the terminal phase of the drug's profile on a semi-logarithmic plot. You will learn to determine whether absorption or elimination is the rate-limiting step, a crucial distinction for correctly interpreting pharmacokinetic data and understanding phenomena like \"flip-flop\" kinetics.",
            "id": "3915207",
            "problem": "A single oral dose of a drug is administered to a human subject and modeled with a one-compartment system with a gastrointestinal absorption compartment. Let $A_{g}(t)$ denote the amount of drug in the gastrointestinal tract and $A_{c}(t)$ denote the amount of drug in the central compartment (systemic circulation). Assume first-order absorption from the gastrointestinal tract into the central compartment with absorption rate constant $k_{a}$ and first-order elimination from the central compartment with elimination rate constant $k_{e}$. Let $F$ denote the fraction absorbed (bioavailability), $D$ the administered dose, and $V$ the apparent volume of distribution. The initial conditions are $A_{g}(0)=D$ and $A_{c}(0)=0$. The plasma concentration is $C(t)=A_{c}(t)/V$. All parameters $F$, $D$, and $V$ are positive and fixed.\n\nStarting from mass conservation and the assumption of first-order processes, derive the late-time behavior of $\\ln C(t)$ and determine the terminal slope $\\frac{d}{dt}\\ln C(t)$ as $t\\to\\infty$. Using the result, compute the terminal slope for the given values $k_{a}=0.1\\ \\text{h}^{-1}$ and $k_{e}=0.3\\ \\text{h}^{-1}$, and identify which structural rate constant governs the terminal phase. Express the terminal slope in $\\text{h}^{-1}$, rounded to three significant figures, and provide the identity of the governing rate constant symbolically. Your final answer must contain both the numerical terminal slope and the governing rate constant, in that order.",
            "solution": "The problem requires the derivation of the terminal slope of the logarithmic plasma concentration curve for a drug administered orally, modeled by a one-compartment system with first-order absorption.\n\nOur starting point is the system of linear ordinary differential equations that describes the amount of drug in the gastrointestinal tract, $A_{g}(t)$, and in the central compartment, $A_{c}(t)$. Based on mass conservation and the assumption of first-order processes, the model is:\n$$ \\frac{dA_{g}}{dt} = -k_{a} A_{g}(t) \\quad \\text{with} \\quad A_{g}(0) = D $$\n$$ \\frac{dA_{c}}{dt} = F \\cdot k_{a} A_{g}(t) - k_{e} A_{c}(t) \\quad \\text{with} \\quad A_{c}(0) = 0 $$\nFirst, we solve the differential equation for $A_{g}(t)$. This is a separable first-order linear ODE with solution:\n$$ A_{g}(t) = D \\exp(-k_{a} t) $$\nNext, we substitute this solution into the second differential equation for $A_{c}(t)$:\n$$ \\frac{dA_{c}}{dt} + k_{e} A_{c}(t) = F k_{a} D \\exp(-k_{a} t) $$\nSolving this first-order linear ODE with the initial condition $A_{c}(0) = 0$ (and assuming $k_{a} \\neq k_{e}$), we obtain the amount of drug in the central compartment:\n$$ A_{c}(t) = \\frac{F k_{a} D}{k_a - k_e} (\\exp(-k_e t) - \\exp(-k_a t)) $$\nThe plasma concentration $C(t)$ is given by $C(t) = A_{c}(t) / V$. It's conventional to write the expression with the terms ordered by rate constant, and ensuring the denominator is positive. Let's write it in a general form:\n$$ C(t) = \\frac{F k_{a} D}{V (k_a - k_e)} (\\exp(-k_e t) - \\exp(-k_a t)) $$\nThis is the Bateman function for oral drug absorption.\n\nThe problem asks for the terminal slope of $\\ln C(t)$ as $t \\to \\infty$. This slope is given by the limit of the derivative of $\\ln C(t)$:\n$$ \\text{Slope} = \\lim_{t\\to\\infty} \\frac{d}{dt} \\ln C(t) $$\nUsing the chain rule, $\\frac{d}{dt} \\ln C(t) = \\frac{1}{C(t)} \\frac{dC(t)}{dt}$.\nFirst, we find $\\frac{dC(t)}{dt}$:\n$$ \\frac{dC(t)}{dt} = \\frac{F k_{a} D}{V (k_a - k_e)} (k_a \\exp(-k_a t) - k_e \\exp(-k_e t)) $$\nNow, we form the ratio:\n$$ \\frac{d}{dt} \\ln C(t) = \\frac{\\frac{F k_{a} D}{V (k_a - k_e)} (k_a \\exp(-k_a t) - k_e \\exp(-k_e t))}{\\frac{F k_{a} D}{V (k_a - k_e)} (\\exp(-k_e t) - \\exp(-k_a t))} = \\frac{k_a \\exp(-k_a t) - k_e \\exp(-k_e t)}{\\exp(-k_e t) - \\exp(-k_a t)} $$\nTo find the limit as $t \\to \\infty$, we identify the slower-decaying exponential term, which is the one with the smaller rate constant in the exponent. This term will dominate the expression for large $t$. The terminal rate constant is $\\lambda_z = \\min(k_a, k_e)$.\n\nCase 1: $k_{a}  k_{e}$. The term $\\exp(-k_{a} t)$ decays more slowly than $\\exp(-k_{e} t)$. We divide the numerator and denominator by $\\exp(-k_{a} t)$:\n$$ \\frac{d}{dt} \\ln C(t) = \\frac{k_{a} - k_{e} \\exp(-(k_{e}-k_{a})t)}{\\exp(-(k_{e}-k_{a})t) - 1} $$\nSince $k_{e} - k_{a} > 0$, as $t \\to \\infty$, the term $\\exp(-(k_{e}-k_{a})t) \\to 0$. Therefore,\n$$ \\lim_{t\\to\\infty} \\frac{d}{dt} \\ln C(t) = \\frac{k_{a} - 0}{0 - 1} = -k_{a} $$\n\nCase 2: $k_{e}  k_{a}$. The term $\\exp(-k_{e} t)$ decays more slowly. We divide the numerator and denominator by $\\exp(-k_{e} t)$:\n$$ \\frac{d}{dt} \\ln C(t) = \\frac{k_{a} \\exp(-(k_{a}-k_{e})t) - k_{e}}{1 - \\exp(-(k_{a}-k_{e})t)} $$\nSince $k_{a} - k_{e} > 0$, as $t \\to \\infty$, the term $\\exp(-(k_{a}-k_{e})t) \\to 0$. Therefore,\n$$ \\lim_{t\\to\\infty} \\frac{d}{dt} \\ln C(t) = \\frac{0 - k_{e}}{1 - 0} = -k_{e} $$\n\nIn both cases, the terminal slope is $-\\min(k_a, k_e)$. The rate constant that governs the terminal phase is the smaller of the two, representing the rate-limiting step in the drug disposition process (either absorption or elimination).\n\nNow, we apply the given numerical values: $k_{a} = 0.1\\ \\text{h}^{-1}$ and $k_{e} = 0.3\\ \\text{h}^{-1}$.\nWe compare the two rate constants: $0.1  0.3$, so $k_{a}  k_{e}$.\nThis corresponds to Case 1. The governing rate constant is $k_{a}$. The drug's terminal decay is absorption rate-limited. This phenomenon is known as \"flip-flop\" kinetics.\n\nThe terminal slope is:\n$$ \\text{Slope} = -k_{a} = -0.1\\ \\text{h}^{-1} $$\nThe problem asks for the numerical value rounded to three significant figures.\n$$ -0.100 $$\nThe governing rate constant is symbolically identified as $k_{a}$.\n\nThe final answer consists of the numerical slope and the symbolic governing rate constant.\nNumerical slope: $-0.100$\nGoverning rate constant: $k_{a}$",
            "answer": "$$ \\boxed{\\begin{pmatrix} -0.100  k_a \\end{pmatrix}} $$"
        }
    ]
}